NF-B/Rel is a family of dimeric transcription factors whose DNA binding domains have considerable homology with an ϳ300-amino-acid region of the v-Rel oncoprotein and were thus called the Rel homology region (24, 31, 48, 49) . Members of the mammalian Rel family include p50 (NFB1), RelA (p65), RelB, c-Rel, and p52 (10, 26, 27) . Classical NF-B is a heterodimer composed of a 50-(p50) and a 65-kDa (RelA) subunit. The NF-B binding element consensus sequence is 5Ј-GGGRNNYYCC-3Ј (where R is a purine and Y is a pyrimidine) (26, 27) . NF-B/Rel transcription factors play important roles in the transcriptional regulation of various cellular genes and viral genes (26) . NF-B-regulated cellular genes are involved in control of cell survival, proliferation, adhesion, and immune and inflammatory responses (5, 26, 45, 53) . Importantly for survival, the promoter of the antiapoptosis Bcl-x L gene has been shown to contain two NF-B elements (14, 25) .
Transcriptionally active NF-B is found constitutively in the nuclei of mature B lymphocytes. In most non-B cells, NF-B complexes are inactive and sequestered in the cytoplasm by direct interaction with specific inhibitor proteins, termed IBs, which need to be phosphorylated and degraded in order for NF-B to translocate to the nucleus (11, 59) . However, RelB is somewhat unusual in that IB-␣ binds only very poorly to this subunit (38) , allowing free nuclear movement of RelB-containing complexes, e.g., RelB-p50 (17) . Activation of NF-B can be induced by numerous agents, including tumor necrosis factor alpha, interleukin-1, and oxidative stress (4, 10, 26, 27) . In addition, NF-B can be activated by several viruses, including cytomegalovirus (CMV), human immunodeficiency virus (HIV) type 1, human T-cell lymphotropic virus type 1, hepatitis B virus, and hepatitis C virus (4, 26, 50) .
Infection by CMV has been shown to stimulate migration and proliferation of smooth muscle cells (SMCs) in culture (37, 56) . CMV has been implicated in the pathogenesis or exacerbation of occlusive vascular diseases, such as atherosclerosis or postangioplasty restenosis (21, 41) . The immediate-early protein 1 (IE1), a 491-amino-acid nuclear phosphoprotein, is one of two major products of the ie gene and is a predominant protein expressed during the immediate-early phase of CMV infection (22, 41) . Although IE1 is believed to regulate viral gene expression by positive-feedback regulation of the ie promoter (29) , other specific functions of this protein have been determined. In particular, IE1 has been found to induce NF-B activity in fibroblasts and Jurkat T cells (50) . Since activation of NF-B has been shown to prevent virus-induced apoptosis, we tested the ability of IE1 to activate the Bcl-x L promoter. Surprisingly, in both vascular SMCs and NIH 3T3 cells, IE1 failed to activate the Bcl-x L promoter although it activated an NF-B-element-driven construct. Using immunohistochemistry, Western blotting, electrophoretic mobility shift assays (EMSA), and transfection analysis into relB knockout mouse embryo fibroblasts (MEFs), we demonstrate that IE1 selectively induces RelB-p50 complexes. Furthermore, we show that RelB-p50 complexes are unable to bind to the Bcl-x L NF-B element or to activate the Bcl-x L promoter. Thus, these results demonstrate selective activation of RelB and p50 by IE1 in SMCs and NIH 3T3 cells and delineate a strong spec-Bio-Rad protein quantitation kit for detergent lysis, according to the manufacturer's directions. For immunoblots, samples (50 g of protein) were separated by electrophoresis through a 10% polyacrylamide-sodium dodecyl sulfate gel and transferred to a polyvinylidene difluoride membrane. Rainbow markers (Amersham, Chicago, Ill.) were used to determine the molecular weight. Following incubation for 1 h in goat anti-rabbit horse radish peroxidase-conjugated secondary antibody (1:2,000 in 5% milk), the proteins were visualized by chemiluminescence, as described previously (3) . Quantitation by scanning densitometry was performed using a Molecular Dynamics 300A computing densitometer.
EMSA. Nuclear extracts were prepared from cells essentially as described previously (54) . Briefly, cells were resuspended in 1 ml of cold hypotonic RSB buffer (10 mM NaCl, 3 mM MgCl 2 , 10 mM Tris [pH 7.4]) containing 0.5% NP-40 detergent plus protease inhibitors as described above. Following a 15-min incubation on ice, the cells were Dounce homogenized until cell lysis occurred. Nuclei were resuspended in two packed nuclear volumes of extraction buffer C (420 mM KCl, 20 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 0.2 mM EDTA, 20% glycerol) plus protease inhibitors as described above and incubated on ice for 30 min. The protein concentration was determined using the Bio-Rad protein assay, as described above. The sequences of the oligonucleotides containing NF-B elements upstream of the c-myc (URE) (20) and Bcl-x L (14) promoters are as follows: c-myc, 5Ј-GATCCAAGTCCGGGTTTTCCCCAACC-3Ј; Bcl-x L , 5Ј-AG TGGGGGCGGGGGGGACTGCCCCCTCTCCTT-3Ј (the underlined regions indicate the core binding element). The Octomer-1 (Oct-1) oligonucleotide has the following sequence: 5Ј-TGTCGAATGCAAATCACTAGAA-3Ј. For the binding reaction, 32 P-labeled oligonucleotide (20,000 to 25,000 cpm) was incubated with 5 g of nuclear extract, 5 l of sample buffer (10 mM HEPES, 4 mM dithiothreitol, 0.5% Triton X-100, and 2.5% glycerol), and 2.5 g of poly(dI-dC) as a nonspecific competitor, and the salt concentration was adjusted to 100 mM using buffer C. The reaction was carried out at room temperature for 30 min. DNA-protein complexes were separated as previously described (54) . Where indicated, excess unlabeled oligonucleotides were added in the binding reaction.
RNA isolation and analysis. Total cellular RNA was isolated by the guanidinium isothiocyanate method from control and transfected cultures in P-150 dishes, and samples (30 g) were subjected to Northern blot analysis, as described previously (51) . The 2.1-kb EcoRI insert of the RelB expression vector was used as a probe. Quantitation by scanning densitometry was performed as described above.
RESULTS
IE1 fails to induce the Bcl-x L promoter. To test the ability of IE1 to induce the Bcl-x L promoter, which is driven by two NF-B elements, transient-transfection analysis was performed in SMCs. Cultures were cotransfected with either the Ϫ298/ϩ22 Bcl-xL-CAT or Ϫ298/ϩ22 mkB Bcl-xL-CAT vector, containing the Bcl-x L promoter (Ϫ298 to ϩ22) with either wild-type or mutant NF-B elements, and increasing doses of the pON2205 construct expressing the full-length CMV IE1 protein. Surprisingly, IE1 failed to induce the wild-type Bcl-x L promoter. In fact, a dose-dependent drop in the activity of the wild-type Bcl-x L promoter was seen with IE1 expression, bringing it down to the basal level of the mutant promoter (Fig. 1A) . To verify that this was not a cell-type-specific event, a similar cotransfection analysis was performed with NIH 3T3 cells. Again, a dose-dependent reduction in Bcl-x L promoter activity was noted (Fig. 1B) . In contrast, cotransfection of p50 with increasing amounts of a RelA expression vector induced the Bcl-x L promoter activity in a dose-dependent fashion in NIH 3T3 cells (Fig. 1C) , confirming the observation of Chen and coworkers (14) . To verify that IE1 expression can indeed transactivate via NF-B elements, we coexpressed IE1 with the E8-CAT reporter vector. In this construct, the TK promoter is driven by two copies of the NF-B regulatory element upstream of the c-myc promoter (URE). IE1 effectively induced NF-B element-driven promoter activity to a maximum of 10-to 12-fold in SMCs and NIH 3T3 cells, confirming the ability of IE1 to induce NF-B activity (Fig. 2) . Taken together, these results indicate that IE1 fails to induce the Bcl-x L promoter, although, it has the ability to induce an NF-B element-driven construct. Thus, we next sought to determine the nature of the NF-B factors induced by IE1.
IE1 induces nuclear colocalization of RelB and p50.
To determine the subunit nature of the NF-B activity induced by IE1, immunohistochemistry was performed. NIH 3T3 cells were selected initially due to their higher level of transfection efficiency compared to the SMCs. Cultures of NIH 3T3 cells were transfected with pON2205 IE1 expression vector or pCMV empty vector DNA and analyzed with antibodies specific for expression of IE1, p50, RelA, RelB, and c-Rel proteins, as described in Materials and Methods. Using a monoclonal IE1 FITC-labeled antibody, intense diffuse staining for IE1 protein was noted over the nucleus, with a much lower level in the cytoplasm, as expected (Fig. 3) . When NF-B subunit expression was examined using Texas Red label, cells positive for IE1 showed nuclear localization of both p50 and RelB (Fig. 3) , which can be better seen in the merged panels. When double label for both the anti-IE1 (green) and anti-RelB or anti-p50 (red) antibodies was examined simultaneously, yellow fluorescence was seen in the nuclei, signifying colocalization of these proteins (Fig. 3, right panels) . In contrast, only a low level of yellow fluorescence was seen with RelA and c-Rel. These data indicate that IE1 induces nuclear localization of the p50 and RelB proteins, whereas RelA and c-Rel remain predominantly in the cytoplasm. Similar analysis for IE1 and the p50, RelB, and RelA subunits was performed in SMC cultures (Fig. 4) . The IE1 protein again predominantly appeared to localize to the nucleus. When the NF-B subunits were exam- vector, 0.5 g of wild-type Ϫ298/ϩ22 Bcl-xL-CAT, 0.5 g of ␤-Gal expression vector, and enough pBluescript to make a total of 2.5 g of DNA and processed as described for panel A. Baseline untreated wild-type Bcl-x L promoter CAT activity was set at 1.
FIG. 2. IE1 induces E8-CAT c-myc URE NF-B element-driven TK promoter activity in SMC and NIH 3T3 cells. Cultures of either SMCs (A) or NIH 3T3 cells (B)
were transiently transfected, in triplicate, with the indicated amounts of pON2205 vector expressing IE1 protein, 0.5 g of E8-CAT vector, 0.5 g of SV40 ␤-Gal expression vector, and enough pBluescript to make a total of 2.5 g of DNA.
After 48 h, the cells were harvested, and CAT activity and ␤-Gal activity were measured. The data presented are the mean of four separate experiments. Baseline untreated E8-CAT activity was set at 1. The results are expressed as mean plus standard error of the mean.
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RelB-p50 FAILS TO ACTIVATE THE Bcl-x L PROMOTER 5739 ined, p50 and RelB subunits were detected in the nuclei of IE1-expressing cells. In contrast, RelA displayed a predominant cytoplasmic localization. Thus, immunohistochemical analysis in both NIH 3T3 and SMC cultures indicates that expression of IE1 leads to selective activation of the p50 and RelB subunits of NF-B.
IE1 selectively induces nuclear localization of NF-B RelB and p50 subunits. To verify the nuclear translocation of NF-B subunits induced by IE1 expression, immunoblot analysis was performed. Forty-eight hours following transfection of NIH 3T3 or SMC cultures with pON2205 IE1 expression vector or pCMV empty vector DNA, cultures were harvested and nu- FIG. 3 . Cytoimmunochemical analysis of the effects of IE1 on nuclear localization of RelB and p50 protein in NIH 3T3 cells. Cultures of NIH 3T3 cells were transfected with either pON2205 IE1 expression plasmid or pCMV empty vector DNA, and split into eight-well chamber slides for analysis, as described in Materials and Methods. For immunofluorescent triple staining, IE1 was visualized with FITC-mouse monoclonal anti-IE1 72 antibody (green), and Texas Red antibodies were used against either the NF-B p50, RelA, RelB, or c-Rel subunit (red), as indicated. For visualization of nuclei, cells were counterstained with Total 3 DNA stain (blue). The slides were observed under an LSM510 laser confocal microscope using a 40ϫ objective. Overlapping FITC and Texas Red signals are also shown (Merged); a yellow-orange color indicates colocalization.
clear and cytoplasmic extracts were prepared. Immunoblot analysis of these extracts confirmed expression of IE1 protein only in NIH 3T3 cells and SMCs transfected with pON2205 vector DNA, as expected (Fig. 5) . Substantial IE1 expression was seen in the nuclei of both NIH 3T3 fibroblasts and SMCs; however, the level in the NIH 3T3 cells was somewhat higher, probably due to the higher transfection efficiency with the fibroblasts than with the SMCs. In cells transfected with the IE1 expression vector, a significant increase in the amount of RelB protein was detected in the cytoplasm. Upon expression of IE1, the level of RelB was found to increase by 6.1 Ϯ 0.4-and 5.8 Ϯ 0.4-fold in the NIH 3T3 cells and SMCs, respectively. Furthermore, consistent with the immunohistochemistry presented above, substantial amounts of RelB can also be detected in the nuclear preparations. Analysis of p50 and p105 subunit expression indicated that IE1 caused a slight reduction of the precursor p105 protein in the cytoplasm and a commensurate increase in the levels of nuclear p50. Of note, no p105 was detected in the nucleus, confirming the purity of the nuclear preparations. In contrast to the effects on RelB and p50, no substantial change in either the level of expression or localization of the c-Rel or RelA protein was detected (Fig. 5) . Equal loading was confirmed by analysis of ␤-actin levels. Taken together, our results indicate that RelB and p50 are selectively induced by IE1 in both SMCs and NIH 3T3 cells.
IE1 does not induce NF-B element-driven reporter activity
in relB ؊/؊ MEFs. Our findings led to the prediction that IE1 would not be able to induce the NF-B element-driven E8-CAT reporter construct in cells that lack the relB gene. To test this hypothesis, relB Ϫ/Ϫ MEFs were cotransfected with 0.5 g of E8-CAT/ml in the absence or presence of 0.25, 0.5, or 0.75 g of pON2205 construct (Fig. 6A) . Expression of IE1 failed to induce E8-CAT activity in the relB Ϫ/Ϫ MEFs in contrast to its effects in NIH 3T3 cells or SMCs, where a dose-dependent increase was observed (Fig. 2) . In fact, IE1 caused a decrease in E8-CAT activity in MEFs lacking RelB expression, which is likely due to the ability of IE1 to induce the p50 NF-B subunit, which binds very avidly but cannot transactivate via the URE and has been shown to repress its activity (35) . To confirm that E8-CAT vector activity can be induced by NF-B in the relB Ϫ/Ϫ MEFs, we performed a similar cotransfection experiment with expression vectors for RelA and p50 (Fig. 6B) . Increasing RelA expression induced E8-CAT in the relB Ϫ/Ϫ MEFs, consistent with our previous observations (34, 35) , demonstrating the ability of the E8-CAT vector to be activated by NF-B. These findings indicate that the functional NF-B activity induced by IE1 contains a RelB subunit. Furthermore, they suggest that IE1 does not induce other transactivating NF-B subunits.
IE1 increases relB mRNA levels. An increase in RelB protein was noted above ( IE1 caused a commensurate increase in relB mRNA levels, Northern blot analysis was performed. RNA was isolated 48 h following transfection of NIH 3T3 and SMC cultures with pON2205 IE1 expression vector or from control, untransfected cultures. Northern blot analysis indicated relB mRNA levels were substantially increased upon expression of IE1 (Fig. 7) . Equal loading was confirmed by ethidium bromide staining of the 18S and 28S rRNAs (Fig. 7) . In three separate experiments, average fold increases of 2.82 Ϯ 0.04 and 4.05 Ϯ 0.08 were noted in the NIH 3T3 and SMC cultures, respectively. Thus, the elevated levels of RelB protein seen upon IE1 expression are due, in part, to increased expression of relB mRNA. RelB-p50 fails to transactivate the Bcl-x L promoter. The failure of IE1 to induce the Bcl-x L promoter suggested that RelB-p50 complexes are unable to transactivate this promoter, in contrast to the observed transactivation by RelA and c-Rel (14) . To test this hypothesis, cultures of either SMCs (Fig. 8A) or NIH 3T3 cells (Fig. 8C) were transfected with the wild-type Bcl-x L promoter construct in the presence of 0.5 g of p50 expression vector and increasing amounts of RelB expression vector ranging from 0.25 to 1.0 g. A dose-dependent decrease in Bcl-x L reporter activity was observed in both SMCs (Fig. 8A) and NIH 3T3 cells (Fig. 8C) . Thus, RelB-p50 complexes are unable to transactivate this promoter. As a control, the SMC or NIH 3T3 cultures were similarly cotransfected with E8-CAT and p50 and RelB expression vectors (Fig. 8B and D) . Cotransfection of p50 and RelB was able to transactivate the E8-CAT NF-B element-driven construct in both cell lines, as expected. Thus, RelB-p50 heterodimeric complexes appear unable to activate the Bcl-x L promoter, consistent with the inability of IE1 to induce the activity of this promoter.
Since expression of RelB reduced the activity of the Bcl-x L promoter, we next tested its ability to affect transactivation by RelA. NIH 3T3 cells were cotransfected with RelA and p50 expression vectors in the absence or presence of vectors expressing either RelB or IE1 (Fig. 8E) . The ϳ3-fold activation of the Bcl-x L promoter seen upon expression of RelA-p50 was completely inhibited upon coexpression of either RelB directly or CMV IE1, which induces synthesis of RelB and p50. These results indicate that RelB can inhibit transactivation of the Bcl-x L promoter by RelA-p50.
RelB-p50 complexes fail to bind to the Bcl-x L NF-B ele- FIG. 5 . CMV IE1 protein induces nuclear levels of RelB and p50 proteins. Cultures (P-100 dish) of either SMCs or NIH 3T3 cells were transfected with 10 g of pON2205 vector expressing IE1 protein (ϩ) or pCMV empty vector DNA (Ϫ). After 48 h, cytoplasmic and nuclear lysates were prepared and samples (30 g) were subjected to immunoblot analysis for IE1, RelB, p50 and p105, RelA, c-Rel,and ␤-actin, as indicated.
FIG. 6. CMV IE1 fails to induce NF-B activity in relB
Ϫ/Ϫ MEFs. Cultures of relB Ϫ/Ϫ MEFs at 50 to 70% confluence were transiently transfected, in triplicate, with 0, 0.25, 0.5, or 0.75 g of either pON2205 vector expressing IE1 protein (A) or RelA expression vector plus 0.5 g of p50 expression vector (B) and 0.5 g of E8-CAT reporter vector, 0.5 g of SV40 ␤-Gal expression vector, and enough pBluescript to make a total of 2.5 g of DNA. After 48 h, the cells were harvested, and CAT activity and ␤-Gal activity were measured. The data presented are the mean of two separate experiments. Baseline untreated E8-CAT activity was set at 1. The results are expressed as the mean plus standard error of the mean.
ment.
We next sought to determine whether RelB-p50 complexes can bind to the Bcl-x L NF-B promoter element. Nuclear extracts were prepared from NIH 3T3 cells transfected with either 10 g of RelB and 5 g of p50 expression vectors or 10 g of pON2205 IE1 vector DNA plus 5 g of pBluescript empty vector DNA or 15 g of pBluescript empty vector DNA as a control. EMSA was performed using as a probe the NF-B element upstream of either the c-myc promoter (which is present in the E8-CAT vector) or the Bcl-x L promoter (Fig.  9A) . Extracts from cells coexpressing RelB and p50 subunits show induction of two major complexes with the c-myc NF-B URE as a probe. Antibody supershift analysis indicated the upper complex (band 2) is composed of RelB-p50 heterodimers, while the lower complex (band 1) contains p50 homodimers, as expected (data not shown). Expression of IE1 resulted in a similar pattern, although a lower level of binding was seen, particularly with respect to band 1. EMSA for Oct-1 binding indicated essentially equal loading in the two extracts (Fig. 9A) . These findings are consistent with the increase in E8-CAT activity observed upon expression of either RelB-p50 or IE1 in NIH 3T3 cells and SMCs.
In contrast, when the Bcl-x L NF-B element was used as a probe, the extracts from RelB plus p50-transfected cells demonstrated an increase in binding of only one complex (band 1) (Fig. 9A) . The upper two complexes were nonspecific, as judged by a competition assay (data not shown). The migration of this complex suggested it consisted of p50 homodimers. To confirm this assessment, NIH 3T3 cells were transfected with 10 g of p50 expression vector plus 5 g of pBluescript empty vector DNA. A complex that comigrates with band 1 was observed (Fig. 9B) . Thus, the Bcl-x L NF-B element does not appear to effectively bind RelB-p50 complexes compared to the c-myc NF-B URE.
Since an inability of RelB-p50 to bind to the Bcl-x L NF-B regulatory element could clearly explain the observed failure to induce the promoter, we used competition analysis to directly compare RelB-p50 binding to the two NF-B elements. The URE was used as a probe. Extracts from the cells expressing RelB-p50 proteins were used in EMSA in the absence or presence of 10-or 100-fold molar excess unlabeled oligonucleotides containing either the URE or Bcl-x L NF-B elements (Fig. 10) . The URE competed very effectively against itself for formation of both complexes. An increasing inhibition of formation of both bands was seen with 10-versus 100-fold molar excess URE. In particular, at 100-fold molar excess, only 24% of the RelB-p50 complex is still present. In contrast, 100-fold molar excess of the Bcl-x L element had no detectable effect against RelB-p50 binding to the NF-B URE (Fig. 10) and even competed much less effectively for formation of band 1, the p50 homodimer complex, consistent with the relative p50 homodimer binding seen in Fig. 9 with the same extract. Similar results were seen with extracts from cells transfected with the IE1 expression vector (data not shown). Together, these results indicate that the Bcl-x L NF-B promoter element does not effectively bind RelB-p50 complexes.
DISCUSSION
Here, we observed that the CMV IE1 protein, which is known to elevate NF-B element-driven activity, failed to induce transactivation of the Bcl-x L promoter in either SMCs or NIH 3T3 cells. Using immunohistochemistry, immunoblotting, and transfection analyses, we have shown that IE1 selectively activates RelB-p50 NF-B heterodimers, which are unable to transactivate the Bcl-x L promoter. Consistent with these observations, IE1 expression led to transactivation of E8-CAT, a c-myc URE NF-B element-driven construct, in SMC and NIH 3T3 cells but not in relB Ϫ/Ϫ MEFs lacking the RelB subunit. RelB is unique among the NF-B family in that it cannot function as a homodimer and only acts as a heterodimer (49) . Unlike RelA or c-Rel, we found that RelB-p50 complexes were unable to bind to the NF-B element that controls activity of the Bcl-x L promoter (14) . (In addition, we observed that a second Bcl-x L NF-B element further upstream of the start site, identified by Glasgow et al. [25] , was also unable to bind to RelB-p50 complexes [data not shown].) Thus, the inactivity of RelB-p50 complexes can be explained by their failure to bind to the specific Bcl-x L promoter NF-B elements. In contrast, RelB-p50 complexes were able to bind to and transactivate via the NF-B element upstream of the c-myc promoter, which explains the ability of IE1 to lead to activation of E8-CAT. The reason for the observed repression of the Bcl-x L promoter activity remains to be determined. Since RelB-p50 does not appear able to bind effectively to the Bcl-x L promoter, an indirect effect mediated via another component of the transcription machinery is likely. The increase in RelB protein induced by IE1 could be related, in part, to an increase in relB mRNA levels. Previously, RelB was shown to interact only weakly with IB-␣ (18, 38) . Thus, the resulting increase in cytoplasmic RelB protein likely leads directly to the observed increase in nuclear levels. Overall, these results indicate the CMV IE1 protein selectively induces RelB-p50 complexes in vascular SMCs and NIH 3T3 cells, and these complexes demonstrate a strong sequence specificity of action.
Previously, IE1 was shown to induce NF-B activity in human fibroblasts and Jurkat T cells, although at that time the subunit nature of the NF-B had not been determined (50) . Here, we demonstrate that the predominant NF-B activity induced by IE1 is RelB-p50. HCMV infection has also been shown to lead to a rapid induction of nuclear NF-B, increased steady-state p50 and RelA mRNA levels, and increased levels FIG. 7 . CMV IE1 protein induces relB mRNA levels. Cultures of SMCs at 50 to 70% confluence were transiently transfected with 10 g of pON2205 vector expressing IE1. After 48 h, RNA was isolated from untransfected (Ϫ) or transfected (ϩ) cultures, and samples (30 g) were subjected to Northern blot analysis for relB mRNA (upper panel). Equal loading and RNA integrity were confirmed by ethidium bromide staining of the 28S and 18S rRNA (lower panel).
VOL. 76, 2002
RelB-p50 FAILS TO ACTIVATE THE Bcl-x L PROMOTER 5743
on February 20, 2013 by PENN STATE UNIV http://jvi.asm.org/ of Sp1 (64) . The activation of Sp1 was found to mediate induction of the expression of the RelA gene, which contains several Sp1 sites (64, 65) . The rapid activation of both Sp1 and NF-B was subsequently shown to be initiated by engagement of cellular receptors for surface glycoproteins on CMV (65). Together with our findings, these studies lead us to hypothesize the following scenario. Upon HMCV infection, engagement of the receptors for the viral surface glycoproteins activates classical NF-B and Sp1 (and thereby RelA mRNA levels), which induce the major ie promoter. The consequent expression of IE1, in turn, leads to the sustained activation of RelB-p50 complexes.
The induction of RelB-p50 likely plays a pivotal role in promoting proliferation of vascular SMCs via control of transcription of two proto-oncogenes c-myb and c-myc. RelB has been demonstrated to control elongation of transcription of the c-myb gene (57, 58) . As first shown by our laboratory, c-Myb is expressed in bovine vascular SMCs and acts as a progression factor, promoting SMC entry into S phase (12, 40, 46) . The role of c-Myb in control of proliferation has been extended to other vascular SMCs in culture and, importantly, has been demonstrated in the in vivo responses of SMCs to vascular injury (28, 33, 39, 52 ; reviewed in reference 36). We have recently found that the c-myc promoter is transactivated upon cotransfection of RelB in combination with either p50 or p52 (W. Yang and G. E. Sonenshein, unpublished observations), consistent with the URE binding and E8-CAT transfection analyses presented here. Multiple laboratories have demonstrated, using either in vitro or in vivo model systems, that c-myc expression is required for the entry of SMCs into S phase. Our laboratory showed that microinjection of both cmyc and c-myb expression vectors was required for quiescent SMCs to enter S phase in culture (40) , while antisense oligonucleotides and ribozyme and dominant-negative-expressing adenoviral vectors have been used in multiple in vivo models of restenosis (52; reviewed in reference 36). Thus, it is likely that the activation of RelB-p50 serves to promote proliferation of vascular SMCs via activation of the c-myc and c-myb genes.
Differential regulation by members of the NF-B family has been seen previously. Frequently, different subunits of the NF-B/Rel family have been shown to selectively interact with members of other protein families (6, 16, 23, 30, 42, 44, 55, 62) . For example, the RelA subunit has been shown to specifically associate with the glucocorticoid and progesterone receptors (30, 62) and the YB-1 protein (44) . We recently reported that the selective interaction of RelA with the arylhydrocarbon Cultures of NIH 3T3 cells were transfected as described above with either the wild-type Ϫ298/ϩ22 Bcl-xL-CAT (C) or E8-CAT (D) reporter vector, and the relative activities are presented as in panels A and B. (E) Cultures of NIH 3T3 cells were transfected (ϩ) as described above with 0.5 g of wild-type Ϫ298/ϩ22 Bcl-xL-CAT and 0.5 g of both RelA and p50 expression vectors in the absence or presence of 0.5 g of CMV IE1 or RelB expression vector plus 0.5 g of SV40 ␤-Gal expression vector and enough pBluescript to make a total of 2.5 g of DNA. After 48 h, the cells were harvested, and CAT activity and ␤-Gal activity were measured. The data presented are the mean of two separate experiments. Baseline untreated Bcl-x L CAT activity was set at 1, and the relative activities are presented.
receptor promotes transcription of the c-myc gene (32) . A similar functional interaction of RelA with the progesterone receptor has been noted (30) . In both of these cases, p50 and c-Rel subunits failed to cooperate to affect the transcriptional activity of the target gene. Thus, interaction with other transcription factors is an important mechanism of subunit-specific regulation. In a few cases, differential binding by NF-B family members has been observed. For example, the HIV long terminal repeat contains two direct repeats of the B site in tandem, which are critical for the initial steps of HIV replication (1, 47) . It has been shown that while RelA-p50 complexes up-regulate the HIV promoter through binding to the tandem NF-B elements in the B site, c-Rel-p50 behaves as a repressor in the context of the HIV long terminal repeat (19) . More recently, transactivation of the c-myb gene by RelB-p50 complexes has been shown to be repressed by RelA-p50 via competition for coactivator usage (43) . Here, we report the selective inability of the NF-B RelB family member to transactivate the Bcl-x L promoter due to its inability to bind effectively to the NF-B regulatory elements upstream of this important survival gene.
A primary effect of IE1 appears to be the induction of relB mRNA. This finding suggests that IE1 likely enhances the rate of relB gene transcription, although other levels of control have not been excluded. In any event, a role for other NF-B subunits in relB mRNA induction is unlikely, given the failure of IE1 to induce E8-CAT activity in relB Ϫ/Ϫ MEFs. Furthermore, we have found that coexpression of IB-␣ fails to block relB mRNA induction (data not shown). RelB was originally identified as an immediate-early gene product in growth factorinduced fibroblasts (49) . RelB is expressed predominantly in lymphoid tissues, where heterodimeric RelB represents the major constitutive B binding activity (13, 38) . Mice with a targeted disruption of relB display inflammatory cell infiltration in several organs, myeloid hyperplasia, and splenomegaly due to extramedullary hematopoiesis. RelB-deficient mice also show abnormal development of thymic medulla and antigenpresenting dendritic cells. In addition to these pathological changes, RelB-deficient mice have multifocal defects in cellu- After 48 h, nuclear extracts were prepared, and samples (5 g) were subjected to EMSA, using the URE NF-B element as a probe, in the absence (none) or presence of 10 or 100ϫ molar excess of the indicated unlabeled oligonucleotide as competitor DNA. The resulting autoradiogram was subjected to densitometry, and the RelB-p50 complexes present are given below as percents relative to the control.
RelB-p50 FAILS TO ACTIVATE THE Bcl- There is now a large body of evidence demonstrating a role for the NF-B/Rel family of transcription factors in promoting the protection of cells from apoptosis. Inhibition of constitutively expressed NF-B leads to apoptosis. Work from our laboratory first showed that inhibition of NF-B activity is necessary and sufficient to cause the death of murine B-cell lymphomas, hepatocytes, and breast cancer cells (2, 3, 9, 54, 63) . RelA-deficient murine embryos die by 14 days of gestation from massive liver degeneration due to apoptosis of liver cells (7) . Similarly, inhibition of NF-B enhances tumor necrosis factor-induced cell death (reviewed in references 5 and 53). Many genes regulated by NF-B that mediate cell survival have now been identified (reviewed in reference 5). It is thus important to determine the NF-B complex specificity required for their activation.
